Biomed Realty Trust (BMR) 23.81 $BMR
Uptrend Call Working As BioMed Realty Trust Stock Rises 21.1% (BMR)
Comtex SmarTrend(R) - Wed Jun 22, 12:52AM CDT
SmarTrend identified an Uptrend for BioMed Realty Trust (NYSE:BMR) on September 17th, 2015 at $19.66. In approximately 9 months, BioMed Realty Trust has returned 21.11% as of today's recent price of $23.81.
BMR: 23.81 (+0.04)
BioMed Realty Trust Up 21.1% Since SmarTrend Uptrend Call (BMR)
Comtex SmarTrend(R) - Tue Jun 07, 12:48AM CDT
SmarTrend identified an Uptrend for BioMed Realty Trust (NYSE:BMR) on September 17th, 2015 at $19.66. In approximately 9 months, BioMed Realty Trust has returned 21.11% as of today's recent price of $23.81.
BMR: 23.81 (+0.04)
21.1% Return Seen to Date on SmarTrend BioMed Realty Trust Call (BMR)
Comtex SmarTrend(R) - Fri May 20, 1:11AM CDT
SmarTrend identified an Uptrend for BioMed Realty Trust (NYSE:BMR) on September 17th, 2015 at $19.66. In approximately 8 months, BioMed Realty Trust has returned 21.11% as of today's recent price of $23.81.
BMR: 23.81 (+0.04)
BioMed Realty Trust Shares Up 21.1% Since SmarTrend's Buy Recommendation (BMR)
Comtex SmarTrend(R) - Thu May 12, 1:56PM CDT
SmarTrend identified an Uptrend for BioMed Realty Trust (NYSE:BMR) on September 17th, 2015 at $19.66. In approximately 8 months, BioMed Realty Trust has returned 21.11% as of today's recent price of $23.81.
BMR: 23.81 (+0.04)
BioMed Realty Trust Has Returned 21.1% Since SmarTrend Recommendation (BMR)
Comtex SmarTrend(R) - Thu May 05, 1:36PM CDT
SmarTrend identified an Uptrend for BioMed Realty Trust (NYSE:BMR) on September 17th, 2015 at $19.66. In approximately 8 months, BioMed Realty Trust has returned 21.11% as of today's recent price of $23.81.
BMR: 23.81 (+0.04)
Shares of BMR Up 21.1% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Mon Apr 11, 1:14PM CDT
SmarTrend identified an Uptrend for BioMed Realty Trust (NYSE:BMR) on September 17th, 2015 at $19.66. In approximately 7 months, BioMed Realty Trust has returned 21.11% as of today's recent price of $23.81.
BMR: 23.81 (+0.04)
Blackstone completes acquisition of BioMed Realty Trust
M2 - Thu Feb 04, 7:01AM CST
BioMed Realty Trust, Inc. (NYSE: BMR) has completed its previously announced acquisition by affiliates of Blackstone Real Estate Partners VIII L.P, valued at USD8.0 billion, the company said. Pursuant to the transaction, holders of shares of common stock of BioMed Realty will be entitled to receive USD23.8239 in cash, without interest, in exchange for each share of common stock they own. Morgan Stanley & Co. LLC acted as lead financial advisor to BioMed Realty, with Raymond James & Associates, Inc. also acting as a financial advisor in connection with this transaction. Latham & Watkins LLP acted as BioMed Realty's legal advisor. Eastdil Secured Group of Wells Fargo Securities LLC, Citigroup Global Markets Inc., JP Morgan Securities LLC, Bank of America Merrill Lynch and Goldman Sachs acted as Blackstone's financial advisors in connection with the transaction. Simpson Thacher & Bartlett LLP acted as legal advisor to Blackstone. BioMed Realty delivers optimal real estate solutions for biotechnology and pharmaceutical companies, scientific research institutions, government agencies and other entities involved in the life science industry. Blackstone has approximately USD92 billion in investor capital under management. Blackstone's real estate portfolio includes hotel, office, retail, industrial and residential properties in the US, Europe, Asia and Latin America.
BMR: 23.81 (+0.04), WFC: 48.27 (-0.08), MS: 27.16 (-0.21)
United Kingdom & Ireland Laboratories (All Sectors) Project Reporting Package Report 2016
M2 - Thu Jan 28, 4:29AM CST
Research and Markets (http://www.researchandmarkets.com/research/vxf8ml/laboratories_all) has announced the addition of the "Laboratories (All Sectors) Project Reporting Package - United Kingdom & Ireland" report to their offering. This laboratories capex project reporting package covers projects associated with the pharmaceutical/biotech throughout the UK and Ireland. All laboratories projects sit within the main process sectors and cover activities such as QA/QC, R&D and new product development (NPD). Projects range from upgrades and modifications to expansions and complete new builds, all with a breadth of scope to include a wide range of equipment as well as associated building and services aspects such as cleanrooms, HVAC, utilities and effluent treatment. One of the most important features of this project reporting is the inclusion of key decision makers which includes contacts with roles encompassing: - External consultants - Technology providers - Design - Engineering - EPC contractors - Equipment specification & selection - Procurement - Planning - Project management - Operations management Within this package there are 59 project reports which include: - Capital Expenditure > 1m - Scheduled to enter procurement phase during 2016 - Project Types: - - New Builds - - Expansions - - Upgrades - - Modifications - Facility Types - - Manufacturing Processes - - Product Development / R&D - - Controlled Storage - - Site Utilities Key Topics Covered: The following information is provided for each project: 1. Company Information - Name - Address - Phone & Fax - Web Site 2. Project Information - Sensitivity - Description - Product Type - Project Location - Project Region - Value - Status 3. Contacts 4. Schedule 5. Notes - Background - Project - Scope - Process Companies Mentioned - 4D Pharma plc - AB Agri Ltd - AarhusKarlshamn UK Ltd - Alcohols Ltd - Babraham Institute - Bartholomews Agri Food Ltd - BioMed Realty Trust Inc - Cara Partners Ltd - Catalent Pharma Solutions Ltd - Cellulac Ltd - Chinook Sciences Ltd - CooperVision Manufacturing Ltd - Cork County Council - HMG Paints Ltd - Harper Adams University - Hologic Ltd - Indivior UK Ltd - Industrial Chemicals Group Ltd - Institute for Animal Health - Keele University Science & Business Park - Merck Sharp & Dohme Ltd - Microbiological Solutions Ltd - National Centre for Food Manufacturing - Oxford Brookes University - Pochin's Ltd - Public Health England - Quantum Pharmaceutical Ltd - Royal Free Hospital NHS Trust - Sandwell & West Birmingham Hospitals - Stryker Orthopaedics - Swallowfield plc - Syngenta UK Ltd - The Centre for Process Innovation - Treatt plc - UCB Pharma Ltd For more information visit http://www.researchandmarkets.com/research/vx...tories_all
BMR: 23.81 (+0.04), MRK: 59.55 (-0.05), HOLX: 35.80 (+0.09)
Blackstone Completes Acquisition Of BioMed Realty Trust
PR Newswire - Wed Jan 27, 1:48PM CST
BioMed Realty Trust, Inc. (NYSE: BMR) (the "Company"
announced today the completion of its previously announced acquisition by affiliates of Blackstone Real Estate Partners VIII L.P. The total transaction value is approximately $8 billion.
BMR: 23.81 (+0.04)
BioMed Realty Trust Announcement Relating To Completion Of Acquisition By Blackstone
PR Newswire - Mon Jan 25, 3:01PM CST
Due to the storm-related closure of government offices in the State of Maryland, BioMed Realty Trust, Inc. (NYSE: BMR) announced that it expects that the closing of the acquisition of BioMed Realty by affiliates of Blackstone Real Estate Partners VIII ("Blackstone" will be delayed until later this week, subject to the satisfaction or waiver of all closing conditions related to the transaction, at which time trading of the Company's shares on the New York Stock Exchange will cease.
BMR: 23.81 (+0.04)
Federal Realty Investment Trust Set to Join the S&P 500; Curtiss-Wright, Pool to Join S&P MidCap 400; Cray, Asbury Automotive to Join S&P SmallCap 600
PR Newswire - Fri Jan 22, 4:49PM CST
S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400 and S&P SmallCap 600 indices:
BMR: 23.81 (+0.04), CW: 85.55 (-0.26), ABG: 56.69 (unch), BRCM: 54.67 (+0.17), POOL: 96.76 (-0.38), FRT: 167.61 (+0.86), MHFI: 107.92 (+1.16), AVGO: 157.41 (-1.18), CRAY: 31.82 (-0.14)
BioMed Realty Trust Announces Tax Treatment Of 2015 Distributions
PR Newswire - Fri Jan 22, 1:05PM CST
BioMed Realty Trust, Inc. (NYSE:BMR) today announced the tax treatment of its 2015 distributions. The following table summarizes, for income tax purposes, the nature of the cash distributions paid by the company to stockholders during the year ended December 31, 2015 and the appropriate 1099DIV box number:
BMR: 23.81 (+0.04)
Uptrend Call Working As BioMed Realty Trust Stock Rises 21.1% (BMR)
Comtex SmarTrend(R) - Wed Jun 22, 12:52AM CDT
SmarTrend identified an Uptrend for BioMed Realty Trust (NYSE:BMR) on September 17th, 2015 at $19.66. In approximately 9 months, BioMed Realty Trust has returned 21.11% as of today's recent price of $23.81.
BMR: 23.81 (+0.04)
BioMed Realty Trust Up 21.1% Since SmarTrend Uptrend Call (BMR)
Comtex SmarTrend(R) - Tue Jun 07, 12:48AM CDT
SmarTrend identified an Uptrend for BioMed Realty Trust (NYSE:BMR) on September 17th, 2015 at $19.66. In approximately 9 months, BioMed Realty Trust has returned 21.11% as of today's recent price of $23.81.
BMR: 23.81 (+0.04)
21.1% Return Seen to Date on SmarTrend BioMed Realty Trust Call (BMR)
Comtex SmarTrend(R) - Fri May 20, 1:11AM CDT
SmarTrend identified an Uptrend for BioMed Realty Trust (NYSE:BMR) on September 17th, 2015 at $19.66. In approximately 8 months, BioMed Realty Trust has returned 21.11% as of today's recent price of $23.81.
BMR: 23.81 (+0.04)
BioMed Realty Trust Shares Up 21.1% Since SmarTrend's Buy Recommendation (BMR)
Comtex SmarTrend(R) - Thu May 12, 1:56PM CDT
SmarTrend identified an Uptrend for BioMed Realty Trust (NYSE:BMR) on September 17th, 2015 at $19.66. In approximately 8 months, BioMed Realty Trust has returned 21.11% as of today's recent price of $23.81.
BMR: 23.81 (+0.04)
BioMed Realty Trust Has Returned 21.1% Since SmarTrend Recommendation (BMR)
Comtex SmarTrend(R) - Thu May 05, 1:36PM CDT
SmarTrend identified an Uptrend for BioMed Realty Trust (NYSE:BMR) on September 17th, 2015 at $19.66. In approximately 8 months, BioMed Realty Trust has returned 21.11% as of today's recent price of $23.81.
BMR: 23.81 (+0.04)
Shares of BMR Up 21.1% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Mon Apr 11, 1:14PM CDT
SmarTrend identified an Uptrend for BioMed Realty Trust (NYSE:BMR) on September 17th, 2015 at $19.66. In approximately 7 months, BioMed Realty Trust has returned 21.11% as of today's recent price of $23.81.
BMR: 23.81 (+0.04)
Blackstone completes acquisition of BioMed Realty Trust
M2 - Thu Feb 04, 7:01AM CST
BioMed Realty Trust, Inc. (NYSE: BMR) has completed its previously announced acquisition by affiliates of Blackstone Real Estate Partners VIII L.P, valued at USD8.0 billion, the company said. Pursuant to the transaction, holders of shares of common stock of BioMed Realty will be entitled to receive USD23.8239 in cash, without interest, in exchange for each share of common stock they own. Morgan Stanley & Co. LLC acted as lead financial advisor to BioMed Realty, with Raymond James & Associates, Inc. also acting as a financial advisor in connection with this transaction. Latham & Watkins LLP acted as BioMed Realty's legal advisor. Eastdil Secured Group of Wells Fargo Securities LLC, Citigroup Global Markets Inc., JP Morgan Securities LLC, Bank of America Merrill Lynch and Goldman Sachs acted as Blackstone's financial advisors in connection with the transaction. Simpson Thacher & Bartlett LLP acted as legal advisor to Blackstone. BioMed Realty delivers optimal real estate solutions for biotechnology and pharmaceutical companies, scientific research institutions, government agencies and other entities involved in the life science industry. Blackstone has approximately USD92 billion in investor capital under management. Blackstone's real estate portfolio includes hotel, office, retail, industrial and residential properties in the US, Europe, Asia and Latin America.
BMR: 23.81 (+0.04), WFC: 48.27 (-0.08), MS: 27.16 (-0.21)
United Kingdom & Ireland Laboratories (All Sectors) Project Reporting Package Report 2016
M2 - Thu Jan 28, 4:29AM CST
Research and Markets (http://www.researchandmarkets.com/research/vxf8ml/laboratories_all) has announced the addition of the "Laboratories (All Sectors) Project Reporting Package - United Kingdom & Ireland" report to their offering. This laboratories capex project reporting package covers projects associated with the pharmaceutical/biotech throughout the UK and Ireland. All laboratories projects sit within the main process sectors and cover activities such as QA/QC, R&D and new product development (NPD). Projects range from upgrades and modifications to expansions and complete new builds, all with a breadth of scope to include a wide range of equipment as well as associated building and services aspects such as cleanrooms, HVAC, utilities and effluent treatment. One of the most important features of this project reporting is the inclusion of key decision makers which includes contacts with roles encompassing: - External consultants - Technology providers - Design - Engineering - EPC contractors - Equipment specification & selection - Procurement - Planning - Project management - Operations management Within this package there are 59 project reports which include: - Capital Expenditure > 1m - Scheduled to enter procurement phase during 2016 - Project Types: - - New Builds - - Expansions - - Upgrades - - Modifications - Facility Types - - Manufacturing Processes - - Product Development / R&D - - Controlled Storage - - Site Utilities Key Topics Covered: The following information is provided for each project: 1. Company Information - Name - Address - Phone & Fax - Web Site 2. Project Information - Sensitivity - Description - Product Type - Project Location - Project Region - Value - Status 3. Contacts 4. Schedule 5. Notes - Background - Project - Scope - Process Companies Mentioned - 4D Pharma plc - AB Agri Ltd - AarhusKarlshamn UK Ltd - Alcohols Ltd - Babraham Institute - Bartholomews Agri Food Ltd - BioMed Realty Trust Inc - Cara Partners Ltd - Catalent Pharma Solutions Ltd - Cellulac Ltd - Chinook Sciences Ltd - CooperVision Manufacturing Ltd - Cork County Council - HMG Paints Ltd - Harper Adams University - Hologic Ltd - Indivior UK Ltd - Industrial Chemicals Group Ltd - Institute for Animal Health - Keele University Science & Business Park - Merck Sharp & Dohme Ltd - Microbiological Solutions Ltd - National Centre for Food Manufacturing - Oxford Brookes University - Pochin's Ltd - Public Health England - Quantum Pharmaceutical Ltd - Royal Free Hospital NHS Trust - Sandwell & West Birmingham Hospitals - Stryker Orthopaedics - Swallowfield plc - Syngenta UK Ltd - The Centre for Process Innovation - Treatt plc - UCB Pharma Ltd For more information visit http://www.researchandmarkets.com/research/vx...tories_all
BMR: 23.81 (+0.04), MRK: 59.55 (-0.05), HOLX: 35.80 (+0.09)
Blackstone Completes Acquisition Of BioMed Realty Trust
PR Newswire - Wed Jan 27, 1:48PM CST
BioMed Realty Trust, Inc. (NYSE: BMR) (the "Company"
announced today the completion of its previously announced acquisition by affiliates of Blackstone Real Estate Partners VIII L.P. The total transaction value is approximately $8 billion. BMR: 23.81 (+0.04)
BioMed Realty Trust Announcement Relating To Completion Of Acquisition By Blackstone
PR Newswire - Mon Jan 25, 3:01PM CST
Due to the storm-related closure of government offices in the State of Maryland, BioMed Realty Trust, Inc. (NYSE: BMR) announced that it expects that the closing of the acquisition of BioMed Realty by affiliates of Blackstone Real Estate Partners VIII ("Blackstone"
will be delayed until later this week, subject to the satisfaction or waiver of all closing conditions related to the transaction, at which time trading of the Company's shares on the New York Stock Exchange will cease. BMR: 23.81 (+0.04)
Federal Realty Investment Trust Set to Join the S&P 500; Curtiss-Wright, Pool to Join S&P MidCap 400; Cray, Asbury Automotive to Join S&P SmallCap 600
PR Newswire - Fri Jan 22, 4:49PM CST
S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400 and S&P SmallCap 600 indices:
BMR: 23.81 (+0.04), CW: 85.55 (-0.26), ABG: 56.69 (unch), BRCM: 54.67 (+0.17), POOL: 96.76 (-0.38), FRT: 167.61 (+0.86), MHFI: 107.92 (+1.16), AVGO: 157.41 (-1.18), CRAY: 31.82 (-0.14)
BioMed Realty Trust Announces Tax Treatment Of 2015 Distributions
PR Newswire - Fri Jan 22, 1:05PM CST
BioMed Realty Trust, Inc. (NYSE:BMR) today announced the tax treatment of its 2015 distributions. The following table summarizes, for income tax purposes, the nature of the cash distributions paid by the company to stockholders during the year ended December 31, 2015 and the appropriate 1099DIV box number:
BMR: 23.81 (+0.04)
